相关实验视频

Updated: Jul 26, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K

使用OLIG2抑制剂CT-179预防Sonic Hedgehog子组中枢细胞瘤的复发

Yuchen Li1,2,3, Chaemin Lim2,4,5, Taylor Dismuke2,6

  • 1QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.

Research square
|June 19, 2023
PubMed
概括

小分子OLIG2抑制剂CT-179在通过向瘤干细胞来治疗Sonic Hedgehog神经母细胞瘤 (SHH-MB) 方面显示出前景. 将CT-179与其他疗法结合使用可能会减少复发并改善SHH-MB患者的存活率.

关键词:
在 CT-179 中,我们可以看到 CT-179中枢细胞瘤 (Medulloblastoma) 是一个在OLIG2中,OLIG2是OLIG2的前身.在临床前的临床前的临床前.

更多相关视频

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.2K
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

1.6K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K